The PHG Foundation has published a new report examining the true potential of AI to deliver genomic medicine. Artificial intelligence for genomic medicine sets out seven policy priorities for decision makers in order to make the best of this potential, while minimsing harms.
New report: Artificial intelligence for genomic medicine
We know that our DNA holds vital information to help tackle many pressing health issues, including (but not limited to) the spread and containment of infectious diseases. However, progress in delivering the health benefits of genomic medicine is challenged by limitations in making sense of vast and complex genomic datasets - limitations AI can slice through. From primer design in DNA sequencing techniques to time sensitive analysis that can speed up treatment decisions, AI has implications for almost every step in the genomics pipeline.
Artificial intelligence for genomic medicine is based on extensive research undertaken throughout 2019, and sets out seven policy imperatives decision-makers and stakeholders must address early for AI to enhance the benefits of genomics for medicine and public health – and avoid the risks.
Artificial Intelligence for genomic medicine is free to download from the PHG Foundation.
The PHG Foundation is a health policy think tank with a special focus on how genomics and other emerging health technologies can provide more effective, personalised healthcare and deliver improvements in population health.